Several nuclear hormone receptors have been associated with inflammatory reactions. Particularly, liver X receptors (LXRs) have recently been identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. LXRs are negative regulators of macrophage inflammatory gene expression. Multiple sclerosis (MS), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. Sweden belongs to the countries with a high MS incidence. In Italy, the MS incidence is lower, except on the island of Sardinia where the incidence is even higher than in Sweden. Subjects from Sardinia are ethnically more homogeneous, and differ from Swedes also regarding genetic background and environment. We studied mRNA expression of several nuclear hormone receptors in blood mononuclear cells (MNC) from female patients with untreated relapsing-remitting MS from Sassari, Sardinia, and Stockholm, Sweden. Sexand age-matched healthy controls (HC) were from both areas. mRNA expression was evaluated by quantitative real-time PCR. We found altered mRNA expression of LXRs, estrogen receptors (ERs), and androgen receptor (AR) in MS. mRNA expression of both LXRA and LXRB is lower in MS from Stockholm but not from Sassari. In particular, LXRA mRNA expression was significantly lower in MS from Stockholm as compared with all groups in the study including MS from Sassari. Low levels of ERA mRNA are seen in MS from both Stockholm and Sassari. The splice variant ERBcx showed significantly higher mRNA expression in MS from Sassari and Stockholm as compared with corresponding HC. In particular, ERBcx mRNA in MS from Sassari was remarkably higher as compared with all other groups in the study. Higher levels of AR mRNA are present in HC from Sassari. The findings indicate that the expression levels of anti-inflammatory nuclear receptor superfamily genes in MS appear to reflect both ethnic and environmental influences. D
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of unknown aetiology. The clinical course is usually characterized by relapses and remissions which, sooner or later, are followed by disease progression and, finally, severe disability. There is evidence for an altered immune balance in MS patients both within the central nervous system and cerebrospinal fluid (CSF) compartments and systemically. The extent of such changes is still under study and their role remains enigmatic, as the pathogenesis of MS is also elusive. Difficulties to identify the cause and to clarify the pathogenesis can in part be attributed to the complex disease traits that involve both genetic and environmental factors. MS has profound heterogeneity in epidemiological distribution, genetic susceptibility, clinical manifestations, pathological lesion patterns, immunological alterations, and clinical responses to the various therapies that are offered and that are at best only partially effective. Taken together, such a complexity seems to indicate a pathogenic heterogeneity in MS.
Prevalence studies point to a north -south gradient for MS in Europe, with a clearly higher prevalence in e.g. Scandinavia compared to countries in the south (Kurtzke, 1997). There is an unexplained clustering of MS on the Italian island of Sardinia when compared to the rest of Southern Europe, reaching prevalence numbers that may even exceed those from e.g. Sweden.
The populations on Sardinia and in Sweden are environmentally as well as ethnically distinct (Underhill et al., 2000; Sotgiu et al., 2004) . Sardinians are genetically more homogeneous and geographically more isolated compared to Swedes. Studies comparing such diverse populations could provide pieces of information to identify risk factors common to MS and, thereby, increase our understanding of the disease pathogenesis.
In a recent study, we presented evidence for the existence in MS in general of a pro-inflammatory state that is reflected by enhanced expression of the cytokine IL-12p40 in both Sassari on Sardinia and Stockholm, Sweden (Huang et al., 2005 
